Bioimpression

Résumé

alt=Bio-imprimante tridimensionnelle développée par la société russe 3D Bioprinting Solutions, capable d'imprimer des organes vivants.|vignette|Bio-imprimante tridimensionnelle développée par la société russe 3D Bioprinting Solutions. La bioimpression ou bio-impression est une application biomédicale des procédés de fabrication additive permettant de produire artificiellement des tissus biologiques. La bio-impression peut être définie comme la structuration spatiale de cellules vivantes et d'autres produits biologiques en les empilant et en les assemblant en utilisant une méthode de dépôt couche par couche assistée par ordinateur pour développer des tissus vivants et des organes pour l'ingénierie tissulaire, la médecine régénérative, la pharmacocinétique et plus généralement la recherche en biologie. C'est une innovation récente qui positionne simultanément des cellules vivantes et des biomatériaux couche par couche pour fabriquer des tissus vivants. L’utilisation principale des organ

Source officielle

https://fr.wikipedia.org/wiki/Bioimpression

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (4)

Publications associées

Chargement

Personnes associées

Chargement

Unités associées

Chargement

Concepts associés (4)

Concepts associés

Chargement

Cours associés (4)

Cours associés

Chargement

Séances de cours associées (4)

Séances de cours associées

Chargement

Volumetric Bioprinting

Paul Delrot, Damien Claude-Marie Loterie, Christophe Moser

MARY ANN LIEBERT, INC2022

Chargement

Recapitulating macro-scale tissue self-organization through organoid bioprinting

Jonathan Brassard, Moritz Hofer, Matthias Lütolf, Mikhail Nikolaev

A 3D bioprinting approach has been developed to facilitate tissue morphogenesis by directly depositing organoid-forming stem cells in an extracellular matrix, with the ability to generate intestinal epithelia and branched vascular tissue constructs. Bioprinting promises enormous control over the spatial deposition of cells in three dimensions(1-7), but current approaches have had limited success at reproducing the intricate micro-architecture, cell-type diversity and function of native tissues formed through cellular self-organization. We introduce a three-dimensional bioprinting concept that uses organoid-forming stem cells as building blocks that can be deposited directly into extracellular matrices conducive to spontaneous self-organization. By controlling the geometry and cellular density, we generated centimetre-scale tissues that comprise self-organized features such as lumens, branched vasculature and tubular intestinal epithelia with in vivo-like crypts and villus domains. Supporting cells were deposited to modulate morphogenesis in space and time, and different epithelial cells were printed sequentially to mimic the organ boundaries present in the gastrointestinal tract. We thus show how biofabrication and organoid technology can be merged to control tissue self-organization from millimetre to centimetre scales, opening new avenues for drug discovery, diagnostics and regenerative medicine.

NATURE RESEARCH2020

Chargement

Additive manufacturing of hierarchical injectable scaffolds for tissue engineering

Thomas Michael Braschler, Niccolo Piacentini, Philippe Renaud

We present a 3D-printing technology allowing free-form fabrication of centimetre-scale injectable structures for minimally invasive delivery. They result from the combination of 3D printing onto a cryogenic substrate and optimisation of carboxymethylcellulose-based cryogel inks. The resulting highly porous and elastic cryogels are biocompatible, and allow for protection of cell viability during compression for injection. Implanted into the murine subcutaneous space, they are colonized with a loose fibrovascular tissue with minimal signs of inflammation and remain encapsulation-free at three months. Finally, we vary local pore size through control of the substrate temperature during cryogenic printing. This enables control over local cell seeding density in vitro and over vascularization density in cell-free scaffolds in vivo. In sum, we address the need for 3D-bioprinting of large, yet injectable and highly biocompatible scaffolds and show modulation of the local response through control over local pore size.

2018

Chargement